JAMA Cardiology
-
January 16, 2020
Global effort tracks causes, treatment of acute heart failure
Patients in North America wait a median of three hours to receive intravenous therapy for acute heart failure, while no other region in the world waited for more than 1.2 hours, according to a global study whose lead author and co-primary investigator is Sean Collins, MD, MSc, professor of Emergency Medicine. -
December 20, 2019
Hepatitis C–positive donors a viable option to expand heart donor pool
Hepatitis C-positive heart donors offer a strategy to safely expand the donor pool and allow more patients to undergo transplant. -
November 21, 2019
Study finds cardiac rehab underused among Medicare patients
Cardiac valve surgery patients who participate in a cardiac rehabilitation program have a 34% lower risk of hospitalizations and a 4.2% lower risk of mortality than patients who do not enroll in cardiac rehab in the year after surgery. -
September 6, 2018
‘Borderline’ lung hypertension should not be ignored: studies
Pulmonary hypertension is a common complication of chronic diseases that occurs when there is increased blood pressure in the arteries carrying blood from the right side of the heart to the lungs. -
April 27, 2017
HIV-infected people have higher risk of heart failure
The first large study to report that HIV-infected people have a significantly higher risk of heart failure in the antiretroviral therapy era has been published in JAMA Cardiology. -
February 8, 2017
Study shows presence of any calcified plaque significantly raises risk of heart disease for people under age 50
A major report led by Vanderbilt investigators found that the mere presence of even a small amount of calcified coronary plaque, more commonly referred to as coronary artery calcium (CAC), in people under age 50 — even small amounts — was strongly associated with increased risk of developing clinical coronary heart disease over the ensuing decade.